Absci (ABSI) Minority Interest (2020 - 2021)
Absci's (ABSI) quarterly Minority Interest came in at $161.4 million in Q2 2021, up 3.16% quarter-over-quarter from $156.4 million in Q4 2020.
Absci (ABSI) Minority Interest (2020 - 2021) Analysis & Trends
Absci has disclosed Minority Interest across 2 years of filings, most recently posting $161.4 million for Q2 2021.
- Minority Interest for Q2 2021 came in at $161.4 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2021 was $161.4 million (changed N/A YoY), and the FY2020 annual result was $156.4 million, changed N/A from the prior year.
- Minority Interest came in at $161.4 million for Q2 2021 at Absci, up from $156.4 million in the prior quarter.
- In the past five years, Minority Interest ranged from a high of $161.4 million in Q2 2021 to a low of $156.4 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 161.38 Mn |
| Dec 31, 2020 | 156.43 Mn |